Trends in State-Level Pharmacy-Based Naloxone Dispensing Rates, 2012-2019.

Trends in State-Level Pharmacy-Based Naloxone Dispensing Rates, 2012-2019.
复制标题

DOI:
10.1016/j.amepre.2021.05.042
复制
发表时间:
2021-12
影响因子:
5.5
通讯作者:
Arifkhanova, Aziza
Arifkhanova, Aziza
中科院分区:
医学2区
文献类型:
--
作者:
Guy Jr, Gery P.;Khushalani, Jaya S.;Jackson, Hannah;Sims, Rebekah St. Clair;Arifkhanova, Aziza

文献摘要

参考文献

被引文献

相似文献

改善获得纳洛酮是一项重要的公共卫生战略在美国这项研究探讨了纳洛酮配药从2012年至2019年的所有50个州和哥伦比亚特区的州一级的趋势。使用来自IQVIA Xponent的数据来检查2012年至2019年和2016年至2019年期间年度纳洛酮分发率和每个高剂量阿片类药物处方分发的纳洛酮处方数量的趋势和地理不平等,以符合疾病控制中心的规定和预防指南为缓解慢性疼痛而开出阿片类药物。使用线性回归估计年度百分比变化。分析于二零二零年进行。从2012年到2019年,所有州和哥伦比亚特区的纳洛酮分配率和每100个高剂量阿片类药物处方中的纳洛酮处方数量都有所增加。平均州级纳洛酮分配率从2012年的每10万人口0.55增加到2016年的45.60和2019年的292.31。同样,每100张高剂量阿片类药物处方中纳洛酮处方的平均数量从2012年的0.002增加到2016年的0.24和2019年的3.04。在纳洛酮分配的两项措施中,地理不平等差距在研究期间增加。在2019年,每100个高剂量阿片类药物处方中分配的纳洛酮处方数量在各州之间从1.04到16.64不等。尽管所有州的纳洛酮分发量都有所增加,但分发率仍然很低,随着时间的推移,州一级的差异越来越大。这些信息可能有助于改善纳洛酮的使用和设计州特定的干预计划。
Improving access to naloxone is an important public health strategy in the U.S. This study examines the state-level trends in naloxone dispensing from 2012 to 2019 for all 50 states and the District of Columbia. Data from IQVIA Xponent were used to examine the trends and geographic inequality in annual naloxone dispensing rates and the number of naloxone prescriptions dispensed per high-dose opioid prescription from 2012 to 2019 and from 2016 to 2019 to correspond with the Centers for Disease Control and Prevention Guideline for Prescribing Opioids for Chronic Pain release. Annual percentage change was estimated using linear regression. Analyses were conducted in 2020. Naloxone dispensing rates and the number of naloxone prescriptions per 100 high-dose opioid prescriptions increased from 2012 to 2019 across all states and the District of Columbia. Average state-level naloxone dispensing rates increased from 0.55 per 100,000 population in 2012 to 45.60 in 2016 and 292.31 in 2019. Similarly, the average number of naloxone prescriptions per 100 high-dose opioid prescriptions increased from 0.002 in 2012 to 0.24 in 2016 and 3.04 in 2019. Across both measures of naloxone dispensing, the geographic inequality gap increased during the study period. In 2019, the number of naloxone prescriptions dispensed per 100 high-dose opioid prescriptions ranged from 1.04 to 16.64 across states. Despite increases in naloxone dispensing across all states, dispensing rates remain low, with substantial variation and increasing disparities over time at the state level. This information may be helpful in efforts to improve naloxone access and in designing state-specific intervention programs.
DOI: 10.1086/700703
发表时间: 2019-02-01
影响因子: 2.2
作者:
Rees, Daniel I.;Sabia, Joseph J.;Latshaw, Joshua
通讯作者: Latshaw, Joshua
DOI: 10.1016/j.japh.2019.11.024
发表时间: 2020-05-01
影响因子: 2.1
作者:
Eldridge, Lori Ann;Agley, Jon;Meyerson, Beth E.
通讯作者: Meyerson, Beth E.
DOI: 10.1016/j.drugalcdep.2020.107896
发表时间: 2020-04-01
影响因子: 4.2
作者:
Haffajee, Rebecca L.;Cherney, Samantha;Smart, Rosanna
通讯作者: Smart, Rosanna
DOI: 10.1007/s11606-015-3394-3
发表时间: 2015-12-01
影响因子: 5.7
作者:
Binswanger, Ingrid A.;Koester, Stephen;Glanz, Jason M.
通讯作者: Glanz, Jason M.
CDC规定慢性疼痛的阿片类药物的指南 - 美国,2016年。
DOI: 10.1001/jama.2016.1464
发表时间: 2016-04-19
期刊: JAMA
影响因子: --
作者:
Dowell D;Haegerich TM;Chou R
通讯作者: Chou R